Srini Rajagopalan

Statistics

Publications

Citations

H-Index

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Williams (United States)

Srini Rajagopalan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, clinical pharmacology, and medication use evaluation.

Publications per year

2010–2016

Publications

Triptan persistency among newly initiated users in a pharmacy claims database

Božena Katić, Srini Rajagopalan, Tony W. Ho et al. · Cephalalgia · 2010 · 36 citations

Pharmacy, Pharmacotherapy, Pharmacy Practice +17

Inadequate pain relief among patients with primary knee osteoarthritis

P.A. Laires, Jorge Laíns, L. Cunha-Miranda et al. · Revista Brasileira de Reumatologia (English Edition) · 2016 · 24 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database

Qiaoyi Zhang, Srini Rajagopalan, Panagiotis Mavros et al. · Current Medical Research and Opinion · 2010 · 20 citations

Medicine, Pharmacology, Clinical Pharmacology +14

The MDRD equation underestimates the prevalence of CKD among blacks and overestimates the prevalence of CKD among whites compared to the CKD-EPI equation: a retrospective cohort study

Pradeep Arora, Srini Rajagopalan, Nilang Patel et al. · BMC Nephrology · 2012 · 19 citations · Full text

Medicine, Nephrology, Clinical Epidemiology +15

1–4 of 4